
In Moldova, the list of drugs compensated from the National Medical Insurance Company funds has been expanded and clarified.
According to the order of the Ministry of Health and the National Medical Insurance Company, the list of reimbursable drugs was supplemented with new internationally accepted names, as well as new doses, forms and indications for treatment with certain drugs. Thus, the list of compensated drugs includes a drug for long-term treatment of patients with osteoporosis - Acidum Alendronicum in the form of tablets with a compensation coefficient of 40%. The new revision presents indications for certain drugs from the list of compensated drugs for the treatment of patients with coronary angioplasty, peripheral arteries, myocardial infarction with atrial fibrillation: Rosuvastatinum and Simvastatinum - for patients with high cardiovascular risk and Valsartanum - for the treatment of hypertensive patients with intolerance to an intolerance to inhibitors enzyme. The changes include the elimination of certain restrictions on the prescription of these reimbursed drugs. In addition, the List of internationally accepted names of compensated drugs has been supplemented with new doses and forms of some drugs: Salmeterolum + Fluticasonum - suspension for pressurized inhalation for the treatment of respiratory diseases in children; Bilastinum And Clemastinum - drugs for the treatment of epedermolysis bullosa; Acetylcysteinum - capsules for the treatment of asthma in children and in the treatment of a new type of coronavirus infection, Acetylcysteinum solution for injection by inhalation with a nebulizer / for endotracheopulmonary instillations, for the treatment of asthma in children and in the treatment of a new type of coronavirus infection. Another change concerns the prescription and dispensing of reimbursable psychotropic drugs. Also, the new edition contains a form for writing prescriptions for compensated drugs from the compulsory medical insurance funds. // 09.08.2021 - InfoMarket